BeOne Medicines Ltd.
ONC
$308.63
-$5.04-1.61%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -195.03M | -409.75M | -662.17M | -857.27M | -506.81M |
| Total Depreciation and Amortization | 181.63M | 175.52M | 168.00M | 84.90M | 90.79M |
| Total Amortization of Deferred Charges | 9.34M | 4.77M | 4.78M | 3.79M | 4.45M |
| Total Other Non-Cash Items | 528.67M | 513.65M | 498.26M | 483.52M | 37.44M |
| Change in Net Operating Assets | 33.51M | -85.25M | -162.59M | -375.96M | -307.47M |
| Cash from Operations | 558.12M | 198.93M | -153.72M | -661.02M | -681.60M |
| Capital Expenditure | -339.68M | -405.80M | -505.97M | -543.34M | -570.37M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -88.73M | -67.03M | -54.75M | -108.21M | -10.00M |
| Cash from Investing | -428.40M | -472.83M | -560.72M | -651.55M | -580.37M |
| Total Debt Issued | 830.57M | 871.44M | 942.52M | 894.36M | 839.88M |
| Total Debt Repaid | -914.45M | -966.93M | -793.38M | -389.25M | -1.04B |
| Issuance of Common Stock | 260.64M | 233.06M | 184.50M | 181.79M | 151.79M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -14.49M | -14.49M | -14.49M | -14.49M | -15.55M |
| Other Financing Activities | -163.17M | -135.98M | -135.98M | -139.83M | -108.76M |
| Cash from Financing | 16.32M | 4.32M | 200.39M | 551.47M | 453.75M |
| Foreign Exchange rate Adjustments | 2.99M | -26.39M | -52.31M | -16.59M | 14.70M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 149.03M | -295.97M | -566.36M | -777.70M | -793.52M |